Analysts See $0.96 EPS for Steris PLC (STE)

October 13, 2017 - By Adrian Erickson

 Analysts See $0.96 EPS for Steris PLC (STE)
Investors sentiment increased to 1 in 2017 Q2. Its up 0.43, from 0.57 in 2017Q1. It is positive, as 1 investors sold Steris PLC shares while 2 reduced holdings. 0 funds opened positions while 3 raised stakes. 406,945 shares or 38.42% more from 293,997 shares in 2017Q1 were reported.
West Coast Fin Llc has 83,918 shares for 2.19% of their portfolio. Prudential Pcl accumulated 6,400 shares. 172,228 are owned by Gotham Asset Ltd Liability Company. Fruth Inv reported 0.61% stake. Hanson And Doremus Investment Mgmt reported 0.05% stake. Yorktown Mgmt & Research Communication Inc reported 4,500 shares or 0.12% of all its holdings. Moreover, Alphamark Advisors Llc has 0.01% invested in Steris PLC (NYSE:STE). Ghp Invest Advisors has invested 0.24% in Steris PLC (NYSE:STE). 12Th Street Asset Mngmt Limited Liability Corp accumulated 103,863 shares or 2.18% of the stock.

Analysts expect Steris PLC (NYSE:STE) to report $0.96 EPS on November, 1.They anticipate $0.07 EPS change or 7.87 % from last quarter’s $0.89 EPS. STE’s profit would be $81.85M giving it 23.30 P/E if the $0.96 EPS is correct. After having $0.85 EPS previously, Steris PLC’s analysts see 12.94 % EPS growth. The stock decreased 1.23% or $1.11 during the last trading session, reaching $89.49. About 450,553 shares traded or 17.53% up from the average. Steris PLC (NYSE:STE) has risen 7.97% since October 14, 2016 and is uptrending. It has underperformed by 8.73% the S&P500.

Steris PLC (NYSE:STE) Ratings Coverage

Among 4 analysts covering Steris (NYSE:STE), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Steris had 5 analyst reports since November 2, 2015 according to SRatingsIntel. The stock of Steris PLC (NYSE:STE) has “Outperform” rating given on Wednesday, August 9 by Raymond James. As per Friday, June 3, the company rating was upgraded by Northcoast. Goldman Sachs initiated the stock with “Neutral” rating in Wednesday, November 30 report.

STERIS plc provides infection prevention and other procedural services and products. The company has market cap of $7.63 billion. The Firm operates through four divisions: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical clients and others. It has a 64.1 P/E ratio.

More news for Steris PLC (NYSE:STE) were recently published by: Seekingalpha.com, which released: “STERIS Plc (STE) Q4 2017 Results – Earnings Call Transcript” on May 09, 2017. Seekingalpha.com‘s article titled: “STERIS Plc (STE) Q1 2018 Results – Earnings Call Transcript” and published on August 08, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.